Walgreens Boots Alliance Inc (NASDAQ:WBA) was the recipient of a significant increase in short interest during the month of February. As of February 15th, there was short interest totalling 23,522,033 shares, an increase of 9.1% from the January 31st total of 21,564,183 shares. Approximately 2.8% of the company’s stock are sold short. Based on an average daily volume of 5,965,356 shares, the short-interest ratio is currently 3.9 days.

A number of analysts recently issued reports on WBA shares. Vetr cut Walgreens Boots Alliance from a “strong-buy” rating to a “buy” rating in a research report on Friday, December 1st. Needham & Company LLC reduced their price objective on Walgreens Boots Alliance to $86.00 and set a “buy” rating for the company in a research report on Wednesday, November 22nd. ValuEngine raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating in a research report on Thursday, January 4th. Robert W. Baird reissued a “buy” rating and set a $82.00 price objective on shares of Walgreens Boots Alliance in a research report on Thursday, January 4th. Finally, Loop Capital set a $90.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Wednesday, January 3rd. One research analyst has rated the stock with a sell rating, ten have issued a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $84.90.

Walgreens Boots Alliance (NASDAQ WBA) opened at $70.58 on Friday. Walgreens Boots Alliance has a 1-year low of $63.82 and a 1-year high of $87.79. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $70,300.00, a PE ratio of 19.50, a price-to-earnings-growth ratio of 1.16 and a beta of 1.21.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 EPS for the quarter, topping analysts’ consensus estimates of $1.27 by $0.01. The business had revenue of $30.74 billion for the quarter, compared to analyst estimates of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The firm’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same period in the previous year, the company posted $1.10 earnings per share. equities research analysts anticipate that Walgreens Boots Alliance will post 5.79 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 12th. Stockholders of record on Thursday, February 15th will be paid a $0.40 dividend. The ex-dividend date is Wednesday, February 14th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.27%. Walgreens Boots Alliance’s payout ratio is presently 44.20%.

In other news, insider Stefano Pessina acquired 98,858 shares of Walgreens Boots Alliance stock in a transaction that occurred on Monday, January 15th. The stock was purchased at an average price of $76.07 per share, with a total value of $7,520,128.06. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 14.80% of the stock is currently owned by company insiders.

Institutional investors have recently bought and sold shares of the company. Pathstone Family Office LLC increased its stake in shares of Walgreens Boots Alliance by 226.6% in the second quarter. Pathstone Family Office LLC now owns 1,179 shares of the pharmacy operator’s stock worth $1,969,000 after purchasing an additional 818 shares during the period. Westside Investment Management Inc. increased its stake in shares of Walgreens Boots Alliance by 10.4% in the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock worth $102,000 after purchasing an additional 125 shares during the period. Zions Bancorporation increased its stake in Walgreens Boots Alliance by 983.3% during the third quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock valued at $105,000 after acquiring an additional 1,239 shares during the period. Bristlecone Advisors LLC bought a new position in Walgreens Boots Alliance during the third quarter valued at about $135,000. Finally, Financial Advocates Investment Management bought a new position in Walgreens Boots Alliance during the fourth quarter valued at about $125,000. Institutional investors and hedge funds own 60.82% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This report was first posted by Watch List News and is the property of of Watch List News. If you are reading this report on another domain, it was stolen and republished in violation of international copyright law. The original version of this report can be read at https://www.watchlistnews.com/short-interest-in-walgreens-boots-alliance-inc-wba-rises-by-9-1/1905752.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.